{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:43:30Z","timestamp":1780317810822,"version":"3.54.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.rdc.2008.08.010","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T03:17:21Z","timestamp":1226287041000},"page":"949-962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Patient-Reported Outcomes Including Fatigue in Primary Sj\u00f6gren's Syndrome"],"prefix":"10.1016","volume":"34","author":[{"given":"Simon J.","family":"Bowman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2008.08.010_bib1","series-title":"Arthritis and Allied Conditions","first-page":"1681","article-title":"Sj\u00f6gren's syndrome","author":"Jonsson","year":"2005"},{"key":"10.1016\/j.rdc.2008.08.010_bib2","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/rheumatology\/keh170","article-title":"Measurement of fatigue and discomfort in primary Sj\u00f6gren's syndrome using a new questionnaire tool","volume":"43","author":"Bowman","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2008.08.010_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/ard.57.5.291","article-title":"Fatigue in primary Sj\u00f6gren's syndrome","volume":"57","author":"Barendregt","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2008.08.010_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/030097400750001761","article-title":"Health-related quality of life in primary Sj\u00f6gren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36","volume":"29","author":"Str\u00f6mbeck","year":"2000","journal-title":"Scand J Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2008.08.010_bib5","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/rheumatology\/kem280","article-title":"Sj\u00f6gren's Systemic Clinical Activity Index (SCAI): a systemic disease activity measure for use in clinical trials in primary Sj\u00f6gren's syndrome","volume":"46","author":"Bowman","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2008.08.010_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","article-title":"Clinical evolution and morbidity and mortality of primary Sj\u00f6gren's syndrome","volume":"29","author":"Skopouli","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2008.08.010_bib7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/ard.60.5.467","article-title":"A longitudinal cohort study of Finnish patients with primary Sj\u00f6gren's syndrome: clinical, immunological, and epidemiological aspects","volume":"60","author":"Pertovaara","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2008.08.010_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/rheumatology\/38.3.245","article-title":"Primary Sj\u00f6gren's syndrome in the North East of England: a long-term follow-up study","volume":"38","author":"Davidson","year":"1999","journal-title":"Rheumatology"},{"issue":"24","key":"10.1016\/j.rdc.2008.08.010_bib9","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1001\/archinte.1993.00410240067007","article-title":"Prevalence of fatigue and chronic fatigue syndrome in a primary care practice","volume":"153","author":"Bates","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rdc.2008.08.010_bib10","series-title":"Chronic fatigue and its syndromes","author":"Wessely","year":"1998"},{"key":"10.1016\/j.rdc.2008.08.010_bib11","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1136\/ard.2003.011825","article-title":"Serum cytokine levels related to multiple dimensions of fatigue in patients with primary Sjogren's syndrome","volume":"63","author":"Hartkamp","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2008.08.010_bib12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/ard.61.3.284","article-title":"Fatigue and immune activity in Sjogren's syndrome","volume":"61","author":"Bax","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2008.08.010_bib13","first-page":"165","article-title":"Anxiety and depression in patients with primary Sjogren's syndrome","volume":"27","author":"Valtysdottir","year":"2000","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2008.08.010_bib14","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/1529-0131(199812)41:12<2230::AID-ART19>3.0.CO;2-D","article-title":"Predictors of subjective fatigue among individuals with rheumatoid arthritis","volume":"41","author":"Huyser","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.rdc.2008.08.010_bib15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/ard.59.11.875","article-title":"Fatigue in primary Sj\u00f6gren's syndrome: Is there a link with the fibromyalgia syndrome?","volume":"59","author":"Giles","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2008.08.010_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/13548500123876","article-title":"Situational patterns in coping with primary Sj\u00f6gren's syndrome","volume":"6","author":"Andersson","year":"2001","journal-title":"Psychol Health Med"},{"key":"10.1016\/j.rdc.2008.08.010_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","article-title":"Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system","volume":"13","author":"Yellen","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.rdc.2008.08.010_bib18","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.rdc.2008.08.010_bib19","first-page":"1896","article-title":"Fatigue assessments in rheumatoid arthritis: comparative performance of visual analogue scales and longer fatigue questionnaires in 7760 patients","volume":"31","author":"Wolfe","year":"2004","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2008.08.010_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2007.083865","article-title":"Reduction of fatigue in Sj\u00f6gren's syndrome with rituximab: results of a randomised, double-blind, placebo controlled pilot study","author":"Dass","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2008.08.010_bib21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","article-title":"The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue","volume":"39","author":"Smets","year":"1995","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.rdc.2008.08.010_bib22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0022-3999(93)90104-N","article-title":"The measurement of fatigue: a new instrument","volume":"37","author":"Schwartz","year":"1993","journal-title":"J Psychosom Res"},{"issue":"4","key":"10.1016\/j.rdc.2008.08.010_bib23","first-page":"677","article-title":"The revised Piper fatigue scale: psychometric evaluation in women with breast cancer","volume":"25","author":"Piper","year":"1998","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.rdc.2008.08.010_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-3999(93)90081-P","article-title":"Development of a fatigue scale","volume":"37","author":"Chalder","year":"1993","journal-title":"J\u00a0Psychosom Res"},{"key":"10.1016\/j.rdc.2008.08.010_bib25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/ard.2007.069690","article-title":"Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis","volume":"67","author":"Wells","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2008.08.010_bib26","series-title":"SF-36 Health Survey. Manual and interpretation guide","author":"Ware","year":"1993"},{"key":"10.1016\/j.rdc.2008.08.010_bib27","article-title":"Measuring fatigue among women with Sj\u00f6gren's syndrome or rheumatoid arthritis: a comparison of the Profile of Fatigue (ProF) and the Multidimensional Fatigue Inventory (MFI)","author":"Goodchild","year":"2007","journal-title":"Musculoskeletal Care"},{"key":"10.1016\/j.rdc.2008.08.010_bib28","first-page":"1","article-title":"The assessment of fatigue in primary Sj\u00f6gren's syndrome","volume":"32","author":"Lwin-T","year":"2003","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.rdc.2008.08.010_bib29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/03009740510026571","article-title":"Assessment of fatigue in primary Sjogren's syndrome: the Swedish version of the profile of fatigue","volume":"34","author":"Strombeck","year":"2005","journal-title":"Scand J Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2008.08.010_bib30","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1177\/0961203396005001081","article-title":"Treatment of primary Sjogren's syndrome with hydroxychloroquine: a retrospective, open-label study","volume":"5","author":"Fox","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2008.08.010_bib31","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/ard.52.5.360","article-title":"Hydroxychloroquine treatment for primary Sj\u00f6gren's syndrome: a two year double blind crossover trial","volume":"52","author":"Kruize","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2008.08.010_bib32","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/art.20146","article-title":"Inefficacy of infliximab in primary Sj\u00f6gren's syndrome","volume":"50","author":"Mariette","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2008.08.010_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/ard.2007.071563","article-title":"Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sj\u00f6gren's syndrome: a randomised controlled trial","volume":"67","author":"Hartkamp","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2008.08.010_bib34","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/rheumatology\/kem004","article-title":"Effects of exercise on aerobic capacity and fatigue in women with primary Sj\u00f6gren's syndrome","volume":"46","author":"Strombeck","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2008.08.010_bib35","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/art.22536","article-title":"Improvement of Sjogren's syndrome after two infusions of rituximab (anti-CD20)","volume":"57","author":"Devauchelle-Pensec","year":"2007","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rdc.2008.08.010_bib36","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/art.21260","article-title":"Rituximab treatment in patients with primary Sjogren's syndrome: an open-label phase II study","volume":"52","author":"Pijpe","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2008.08.010_bib37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.2006.057919","article-title":"Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sj\u00f6gren's syndrome","volume":"66","author":"Seror","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"9 Suppl","key":"10.1016\/j.rdc.2008.08.010_bib38","first-page":"S445","article-title":"Longitudinal analysis of lymphocyte subsets in patients with primary Sjogren's syndrome (pSS) treated with rituximab: results from an open-label clinical trial","volume":"56","author":"Levesque","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2008.08.010_bib39","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Epratuzimab (humanised anti-CD22 antibody) in primary Sjogren's syndrome: a cohort study on cancer incidence and lymphoma predictors","volume":"65","author":"Steinfeld","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2008.08.010_bib40","first-page":"2115","article-title":"Fatigue, rheumatoid arthritis, anti-tumour necrosis factor therapy: an investigation in 24,831 patients","volume":"31","author":"Wolfe","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2008.08.010_bib41","first-page":"512","article-title":"Key questions in a dry eye history","volume":"57","author":"McMonnies","year":"1986","journal-title":"J Am Optom Assoc"},{"key":"10.1016\/j.rdc.2008.08.010_bib42","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2008.08.010_bib43","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0002-8177(87)54012-0","article-title":"Subjective reports of xerostomia and objective measures of salivary gland performance","volume":"115","author":"Fox","year":"1987","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.rdc.2008.08.010_bib44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1067\/moe.2001.111551","article-title":"Development of a visual analogue scale questionnaire for subjective assessment of salivary dysfunction","volume":"91","author":"Pai","year":"2001","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.rdc.2008.08.010_bib45","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1368-8375(00)00063-4","article-title":"Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy","volume":"37","author":"Henson","year":"2001","journal-title":"Oral Oncol"},{"key":"10.1016\/j.rdc.2008.08.010_bib46","first-page":"3","article-title":"Development and evaluation of the Oral Health Impact Profile","volume":"11","author":"Slade","year":"1994","journal-title":"Community Dent Health"},{"key":"10.1016\/j.rdc.2008.08.010_bib47","first-page":"12","article-title":"The Xerostomia Inventory: a multi-item approach to measuring dry mouth","volume":"16","author":"Thomson","year":"1999","journal-title":"Community Dent Health"},{"key":"10.1016\/j.rdc.2008.08.010_bib48","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1034\/j.1600-0714.2003.t01-1-00109.x","article-title":"The development and initial validation of the Liverpool Sicca index to assess symptoms and dysfunction in patients with primary Sjogren's syndrome","volume":"32","author":"Field","year":"2003","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.rdc.2008.08.010_bib49","first-page":"1259","article-title":"Validation of the Sicca Symptoms Inventory (SSI) for clinical studies of Sj\u00f6gren's syndrome","volume":"30","author":"Bowman","year":"2003","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2008.08.010_bib50","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archinte.159.2.174","article-title":"Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sj\u00f6gren's syndrome","volume":"159","author":"Vivino","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rdc.2008.08.010_bib51","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.rdc.2008.08.010_bib52","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1477-7525-2-44","article-title":"Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sj\u00f6gren's syndrome-related dry eye","volume":"2","author":"Vitale","year":"2004","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.rdc.2008.08.010_bib53","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.57.1.20","article-title":"Weak association between subjective symptoms of and objective testing for dry eyes and dry mouth: results from a population based study","volume":"57","author":"Hay","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2008.08.010_bib54","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archinte.162.11.1293","article-title":"Cevimeline for the treatment of xerostomia in patients with Sj\u00f6gren's syndrome. A randomized trial","volume":"162","author":"Fife","year":"2002","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.rdc.2008.08.010_bib55","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/art.510","article-title":"A double-blind, randomized, placebo-controlled study of cevimeline in Sj\u00f6gren's syndrome patients with xerostomia and keratoconjunctivitis sicca","volume":"46","author":"Petrone","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2008.08.010_bib56","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/jir.1998.18.255","article-title":"Single-blinded controlled trial of low-dose oral IFN-a for the treatment of xerostomia in patients with Sjogren's syndrome","volume":"18","author":"Shiozawa","year":"1998","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.rdc.2008.08.010_bib57","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/art.11199","article-title":"Treatment of primary Sjogren's syndrome with low-dose human interferon \u03b1 administered by the oromucosal route: combined phase III results","volume":"49","author":"Cummins","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2008.08.010_bib58","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","article-title":"Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomised trial","volume":"107","author":"Stevenson","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.rdc.2008.08.010_bib59","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomised studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.rdc.2008.08.010_bib60","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/rheumatology\/40.10.1180","article-title":"Revisiting Sj\u00f6gren's syndrome in the new millennium: perspectives on assessment and outcome measures. Report of a workshop held on 23 March 2000 at Oxford, UK","volume":"40","author":"Bowman","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2008.08.010_bib61","first-page":"143","article-title":"Outcome measures for Sj\u00f6gren's syndrome, April 10\u201311, 2003, Bethesda, Maryland, U S A","volume":"32","author":"Pillemer","year":"2005","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2008.08.010_bib62","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/art.22658","article-title":"Sj\u00f6gren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sj\u00f6gren's syndrome, derived from an analysis of a cohort of Italian patients","volume":"56","author":"Vitali","year":"2007","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X08000823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X08000823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:08:25Z","timestamp":1760180905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X08000823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0889857X08000823"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2008.08.010","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-Reported Outcomes Including Fatigue in Primary Sj\u00f6gren's Syndrome","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2008.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}